Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study

N.C. Tebutt, K. Wilson, V.J. Gebski, M.M. Cummins, D. Zannino, Guy Van Hazel, B. Robinson, A. Broad, V. Ganiu, S.P. Ackland, G. Forgeson, D. Cunningham, M.P. Saunders, M.R. Stockler, Y. Chua, J.R. Zalbcberg, R.J. Simes, T.J. Price

    Research output: Contribution to journalArticlepeer-review

    359 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3191-3198
    JournalJournal of Clinical Oncology
    Issue number19
    Publication statusPublished - 2010

    Cite this